The GSEA was carried out to identify the significantly enriched pathways between HER2+ and HER2− breast cancer (BC) patients amongst gene sets related to the following: C2, C5 BP and MF, C6, and C7. The gene discussed is ERBB2; the disease is breast carcinoma.